Fasken Martineau DuMoulin LLP advised Elemental Altus Royalties Corp. on the acquisition. Elemental Altus Royalties Corp. (TSXV: ELE) (OTCQX: ELEMF) completed the acquisition of two existing...
Elemental Altus Royalties Corp.’s Acquisition of Royalties from RCF Opportunities Fund
Elemental Altus Royalties Corp.’s Acquisition of Royalties on Cactus Project
Fasken Martineau DuMoulin LLP advised Elemental Altus Royalties Corp. on the transaction. Elemental Altus Royalties Corp. completed the acquisition of two existing royalties from RCF Opportunities Fund...
Nighthawk Gold Corp.’s C$11.3 Million Private Placement
Fasken Martineau DuMoulin LLP acted for National Bank Financial Inc. on the matter. On August 4, 2023, National Bank Financial Inc., in its capacity as lead...
Trigon Metals’ C$5 Million Private Placement
Fasken Martineau DuMoulin LLP advised Beacon Securities Limited in the transaction. Trigon Metals Inc. announced its brokered private placement offering of 25,000,000 units at a price of...
Biolab Pharma Ltd.’s Acquisition of Exzell Pharma Inc.
Fasken Martineau DuMoulin LLP advised Exzell Pharma Inc. on the sale. On August 4, 2022, Exzell Pharma Inc. (“Exzell”), a Canadian pharmaceutical business, announced its sale...
Elemental Royalties Corp.’s Merger with Altus Strategies Plc
Elemental’s financial advisor was Canaccord Genuity Limited, assisted by Wildeboer Dellelce LLP. Fasken Martineau DuMoulin LLP acted as legal counsel to Elemental. Longview Communications and Public...